Haleon shares fall 3.4% as revenue growth falls short of the company's own medium-term target

Haleon shares fall 3.4% as revenue growth falls short of the company's own medium-term target Proactive uses images sourced from Shutterstock A weak cold and flu season and a cautious American consumer pushed organic growth to 3%, a full percentage point below the floor of what Haleon has promised investors Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 3.4% to 392.1p on Wednesday after the consumer health group reported full-year organic revenue growth of 3%, missing the 4-6% medium-term range it has set as i ...